Hans-Georg Eckhardt

Hans-Georg Eckhardt

Auto-generated profile, based on publicly available information

Hans-Georg Eckhardt

School of Chemistry University College Dublin Dublin Ireland

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017 in Annals of Surgery
Verified
Journal Article
Closed access
JEJessie A Elliott
Jessie A Elliott
Neil G. DochertyNeil G. Docherty
Neil G. Docherty
HEHans-Georg Eckhardt
Hans-Georg Eckhardt
SDSuzanne L. Doyle
Suzanne L. Doyle
EGEmer Guinan
Emer Guinan
Carel W. Le RouxCarel W. Le Roux
Carel W. Le Roux
To prospectively characterize changes in body weight, satiety, and postprandial gut hormone profiles following esophagectomy. With improved oncologic outcomes in esophageal cancer, there is an increasing focus on functional status and health-related quality of life in survivorship. Early satiety and weight loss are common after esophagectomy, but the pathophysiology of these phenomena remains poorly understood. In this prospective study, consecutive patients undergoing esophagectomy with gastric conduit reconstruction were studied preoperatively and at 10 days, 6 weeks, and 3 months postoperatively. Glucagon-like peptide 1 (GLP-1) immunoreactivity of plasma collected immediately before and at 15, 30, 60, 90, 120, 150, and 180 minutes after a standardized 400-kcal mixed meal was determined. Gastrointestinal symptom scores were computed using European Organization for Research and Treatment of Cancer questionnaires. Body weight loss at 6 weeks and 3 months postoperatively among 13 patients undergoing esophagectomy was 11.1 ± 2.3% (P < 0.001) and 16.3 ± 2.2% (P < 0.0001), respectively. Early satiety (P = 0.043), gastrointestinal pain and discomfort (P = 0.01), altered taste (P= 0.006), and diarrhea (P= 0.038) scores increased at 3 months postoperatively. Area under the curve for the satiety gut hormone GLP-1 was significantly increased from 10 days postoperatively (2.4 ± 0.2-fold increase, P < 0.01), and GLP-1 peak increased 3.8 ± 0.6-, 4.7 ± 0.8-, and 4.4 ± 0.5-fold at 10 days, 6 weeks, and 3 months postoperatively (all P < 0.0001). Three months postoperatively, GLP-1 area under the curve was associated with early satiety (P = 0.0002, R = 0.74), eating symptoms (P = 0.007, R = 0.54), and trouble enjoying meals (P = 0.0004, R = 0.73). After esophagectomy, patients demonstrate an exaggerated postprandial satiety gut hormone response, which may mediate postoperative changes in satiety, body weight, and gastrointestinal quality of life.

18 March 2019 in British Journal of Surgery
Verified
Journal Article
Closed access
PDF file
JEJessie A Elliott
Jessie A Elliott
Neil G. DochertyNeil G. Docherty
Neil G. Docherty
CMC. F. Murphy
C. F. Murphy
HEH.‐G. Eckhardt
H.‐G. Eckhardt
SDS. L. Doyle
S. L. Doyle
Carel W. Le RouxCarel W. Le Roux
Carel W. Le Roux

2 December 2015 in European Journal of Organic Chemistry
Verified
Journal Article
Open access
PDF file
CMClaire Moylan
Claire Moylan
LRLuke Rogers
Luke Rogers
YSYasser M. Shaker
Yasser M. Shaker
MDMia Davis
Mia Davis
HEHans‐Georg Eckhardt
Hans‐Georg Eckhardt
Mathias SengeMathias Senge
Mathias Senge
Rational building strategies and appropriate synthons have been developed for the use of triptycene as a rigid presenting scaffold. Palladium‐catalyzed cross‐coupling reactions, such as Sonogashira and Suzuki couplings, were used to install a variety of different synthetic handles around the triptycene periphery in a high‐yielding and controlled manner. These triptycene molecular handles were investigated for their potential in the construction of molecular arrays with defined spatial orientation e.g., for host‐guest interactions or drug delivery systems. Such molecular synthons afforded expansion from the triptycene core by employing arm extension to increase the internal free volume characteristic of triptycene scaffolds for such applications. In addition, a range of mesogenic and glycosyl triptycene derivatives were achieved as a synthetic proof of concept for future work on potential drug delivery systems.

1 February 2019 in The American Journal of Clinical Nutrition
Verified
Journal Article
Closed access
JEJessie A Elliott
Jessie A Elliott
Neil G. DochertyNeil G. Docherty
Neil G. Docherty
JHJacqueline Haag
Jacqueline Haag
HEHans-Georg Eckhardt
Hans-Georg Eckhardt
NRNarayanasamy Ravi
Narayanasamy Ravi
Carel W. Le RouxCarel W. Le Roux
Carel W. Le Roux
Reduced appetite and weight loss are common after esophagectomy (ES), and this cohort demonstrates an exaggerated postprandial satiety gut hormone response. Satiety gut hormones modulate food reward, resulting in reduced energy intake. This study aimed to determine the effect of satiety gut hormone modulation by measuring the effect of the somatostatin analog octreotide on appetitive behavior among patients after ES. In this randomized, double-blind, placebo-controlled crossover study, patients ≥1 y after ES and matched controls received either 1 mL 0.9% saline or 1 mL (100 μg) octreotide subcutaneously before completing a progressive ratio task. A measure of appetitive behavior, this task requires subjects to undertake progressively increasing amounts of work to obtain a sweet-fat reinforcer; the final completed increment (breakpoint) represents reinforcer reward value. Separate cohorts were studied in the fasted or 1-h postprandial states. Thirty-six subjects (ES, n = 18; matched controls, n = 18) were studied. The ES subjects were 2.5 ± 0.3 y postoperation and had a weight loss of 14.6% ± 2.6% and elevated postprandial glucagon-like peptide 1 compared with controls (49.2 ± 13.4 compared with 20.2 ± 2.3 pM; P = 0.04). Octreotide did not alter the breakpoint among ES or control subjects when tested in a fasting condition (ES: 980 ± 371 compared with 1700 ± 584 clicks; P = 0.16; controls: 1056 ± 274 compared with 1124 ± 273 clicks; P = 0.81). When tested 1 h postprandially, octreotide was associated with an increased breakpoint compared with placebo among ES subjects (322 ± 143 compared with 246 ± 149 clicks; P = 0.04) but not controls (248 ± 119 compared with 247 ± 120 clicks; P = 0.97). Attenuation of the exaggerated postprandial satiety gut hormone response is associated with increased appetitive behavior toward a sweet-fat stimulus among patients post-ES. Suppression of satiety gut hormones may be a novel target to increase appetite, food intake, and body weight among patients after ES. This study was registered at clinicaltrials.gov as NCT02381249.

6 March 2025 in ChemCatChem
Verified
Journal Article
Open access
RARaphaël Abolivier
Raphaël Abolivier
HEHans‐Georg Eckhardt
Hans‐Georg Eckhardt
JMJimmy Muldoon
Jimmy Muldoon
MFMichael Fay
Michael Fay
James A. SullivanJames A. Sullivan
James A. Sullivan
In this paper, a series of bimetallic Ni‐Cu/ZSM‐5 catalysts was prepared, characterized, and investigated in the hydrogenolysis of lignin model compounds. This study is aimed at the understanding of the properties of supported bimetallic nanoparticles prepared via a facile hydrothermal/reduction synthesis for potential applications within biorefining facilities. Changes in metal loadings and relative metal contents were found to have important effects on the separation of the metals within the nanoparticles, and this in turn affected the reactivity of the materials for the investigated reaction. The results also highlight the importance of lignin extraction methods for the future of biorefining.